Details
Stereochemistry | RACEMIC |
Molecular Formula | C20H19N3O4S.ClH |
Molecular Weight | 433.908 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.COC1=CC2=C(C=C1)N=C(COC3=CC=C(CC4SC(=O)NC4=O)C=C3)N2C
InChI
InChIKey=LKKAMJRUPIIUTC-UHFFFAOYSA-N
InChI=1S/C20H19N3O4S.ClH/c1-23-16-10-14(26-2)7-8-15(16)21-18(23)11-27-13-5-3-12(4-6-13)9-17-19(24)22-20(25)28-17;/h3-8,10,17H,9,11H2,1-2H3,(H,22,24,25);1H
Molecular Formula | C20H19N3O4S |
Molecular Weight | 397.448 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Rivoglitazone hydrochloride (CS-011) is a thiazolidinedione-derivative peroxisome proliferator–activated receptor (PPAR)-γ agonist. It has been developed as potential treatment in type 2 diabetes mellitus and was shown to decrease plasma glucose and triglyceride levels in a dose-dependent manner in animals. Phase II and III clinical studies have assessed the efficacy and safety of rivoglitazone hydrochloride in patients with type 2 diabetes mellitus.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 01:50:31 GMT 2023
by
admin
on
Sat Dec 16 01:50:31 GMT 2023
|
Record UNII |
60HQU68H8A
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
299176-11-7
Created by
admin on Sat Dec 16 01:50:31 GMT 2023 , Edited by admin on Sat Dec 16 01:50:31 GMT 2023
|
PRIMARY | |||
|
SUB107720
Created by
admin on Sat Dec 16 01:50:31 GMT 2023 , Edited by admin on Sat Dec 16 01:50:31 GMT 2023
|
PRIMARY | |||
|
9889104
Created by
admin on Sat Dec 16 01:50:31 GMT 2023 , Edited by admin on Sat Dec 16 01:50:31 GMT 2023
|
PRIMARY | |||
|
100000141986
Created by
admin on Sat Dec 16 01:50:31 GMT 2023 , Edited by admin on Sat Dec 16 01:50:31 GMT 2023
|
PRIMARY | |||
|
60HQU68H8A
Created by
admin on Sat Dec 16 01:50:31 GMT 2023 , Edited by admin on Sat Dec 16 01:50:31 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |